Learn how integrated platforms, single sign-on tools, and streamlined training approaches can reduce site burden while supporting compliance and study startup.
Steve Rosenberg
Advertisement
Articles by Steve Rosenberg
2025 SCRS Global Site Solutions Summit: How Sites Can Overcome Technology Burdens in Clinical Trials
Steve Rosenberg, CEO, uMotif, discusses the challenges sites face with eCOA, eConsent, and ePRO platforms and the support needed to reduce technical burdens.
Discover how evolving clinical trial trends are reshaping patient and site experiences—and the steps sponsors can take to stay ahead—in this conversation with uMotif CEO Steve Rosenberg at SCOPE Summit 2025.
Steve Rosenberg, CEO of uMotif gives commentary on providing clinical trial patients with the best experience possible.
For programs such as the Precision Medicine Initiative’s Cancer MoonShot to have a chance at success, following a set of key technology mandates will be critical.
Advertisement
Latest Updated Articles
2025 SCRS Global Site Solutions Summit: How Sites Can Overcome Technology Burdens in Clinical TrialsPublished: September 30th 2025 | Updated:
2025 SCRS Global Site Solutions Summit: How Technology Partners Can Simplify Site Workflows and TrainingPublished: October 3rd 2025 | Updated:
The Promise of Precision MedicinePublished: April 1st 2016 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Thermo Fisher, Lundbeck Announce New OpenAI Partnerships Advancing AI in Drug Development
2
ACT Brief: AI Partnerships, Data-Driven Site Activation, and FDA Approval for Omvoh’s Single-Injection Regimen
3
Imfinzi Regimen Demonstrates 22% Survival Benefit in Early Gastric and GEJ Cancer
4
Using Global Patient Data to Design Smarter, More Inclusive Clinical Trials
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
